144 related articles for article (PubMed ID: 37130554)
1. High 4-1BB Expression in PBMCs and Tumor Infiltrating Lymphocytes (TILs) in Patients with Head and Neck Squamous Cell Carcinoma.
Bin-Alee F; Chunthagonesupawit N; Meesakul T; Diloktaweewattana A; Mahattanasakul P; Mutirangura A; Ruangritchankul K; Keelawat S; Kitkumthorn N
Eur J Dent; 2024 Feb; 18(1):236-242. PubMed ID: 37130554
[TBL] [Abstract][Full Text] [Related]
2. 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8
Kim HD; Park S; Jeong S; Lee YJ; Lee H; Kim CG; Kim KH; Hong SM; Lee JY; Kim S; Kim HK; Min BS; Chang JH; Ju YS; Shin EC; Song GW; Hwang S; Park SH
Hepatology; 2020 Mar; 71(3):955-971. PubMed ID: 31353502
[TBL] [Abstract][Full Text] [Related]
3. [The regulatory function of tumor-infiltrating Th9 cells to anti-tumor activity of CD8(+) T cells in patients with gastric cancer].
Sun PS; Gao ZJ; Fan LX; Liu YF; Chen BH; Mu SZ; Yan ZQ
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1186-1193. PubMed ID: 36380667
[No Abstract] [Full Text] [Related]
4. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity.
Wan YL; Zheng SS; Zhao ZC; Li MW; Jia CK; Zhang H
World J Gastroenterol; 2004 Jan; 10(2):195-9. PubMed ID: 14716821
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of CD4+ and CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
Borsetto D; Tomasoni M; Payne K; Polesel J; Deganello A; Bossi P; Tysome JR; Masterson L; Tirelli G; Tofanelli M; Boscolo-Rizzo P
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33668519
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis for the biomarkers of the tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma.
You Y; Du Z; Tian Z; Xu G; Wang Y; Xiao M
Transl Cancer Res; 2021 Aug; 10(8):3716-3725. PubMed ID: 35116672
[TBL] [Abstract][Full Text] [Related]
7. 4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39
Leem G; Park J; Jeon M; Kim ES; Kim SW; Lee YJ; Choi SJ; Choi B; Park S; Ju YS; Jung I; Kim S; Shin EC; Lee JY; Park SH
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33335029
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral CD103
Ren S; Lan T; Wu F; Chen S; Jiang X; Huo C; Li Z; Xie S; Wu D; Wang R; Li Y; Qiu L; Huang G; Li S; Wang X; Cen M; Cai T; Lin Z; Li J; Li B
Cancer Commun (Lond); 2023 Oct; 43(10):1143-1163. PubMed ID: 37658605
[TBL] [Abstract][Full Text] [Related]
9. Tumor Infiltrating Lymphocytes are Prognostic Factors and Can Be Markers of Sensitivity to Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma.
Suzuki H; Kawasaki Y; Miura M; Hatakeyama H; Shina K; Suzuki S; Yamada T; Suzuki M; Ito A; Omori Y
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1271-1278. PubMed ID: 35485685
[TBL] [Abstract][Full Text] [Related]
10. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors.
de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM
Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic analysis of peripheral blood mononuclear cells in head and neck squamous cell carcinoma patients.
Bin-Alee F; Arayataweegool A; Buranapraditkun S; Mahattanasakul P; Tangjaturonrasme N; Hirankarn N; Mutirangura A; Kitkumthorn N
Oral Dis; 2021 Sep; 27(6):1394-1402. PubMed ID: 32892371
[TBL] [Abstract][Full Text] [Related]
12. Fewer tumour-specific PD-1
Xu K; Fu Y; Han Y; Xia R; Xu S; Duan S; Zhang Z; Li J
Br J Cancer; 2020 Sep; 123(6):932-941. PubMed ID: 32616847
[TBL] [Abstract][Full Text] [Related]
13. PD-1/PD-L1 Axis, Rather Than High-Mobility Group Alarmins or CD8+ Tumor-Infiltrating Lymphocytes, Is Associated With Survival in Head and Neck Squamous Cell Carcinoma Patients Who Received Surgical Resection.
Yang F; Zeng Z; Li J; Zheng Y; Wei F; Ren X
Front Oncol; 2018; 8():604. PubMed ID: 30619746
[TBL] [Abstract][Full Text] [Related]
14. Expression of PD-L1 and CD4+ tumor-infiltrating lymphocytes predict survival in head and neck squamous cell carcinoma.
Fu ZM; Zhang DJ; Guo YY; Han S; Guo F; Bai J; Wan YN; Guan GF; Sun KW; Yang N
Mol Clin Oncol; 2022 Mar; 16(3):59. PubMed ID: 35111324
[TBL] [Abstract][Full Text] [Related]
15. Increased co-expression of 4-1BB with PD-1 on CD8+ tumor-infiltrating lymphocytes is associated with improved prognosis and immunotherapy response in cervical cancer.
Zhu X; Feng Y; Fan P; Dong D; Yuan J; Chang C; Wang R
Front Oncol; 2024; 14():1381381. PubMed ID: 38756662
[TBL] [Abstract][Full Text] [Related]
16. The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
de Ruiter EJ; Ooft ML; Devriese LA; Willems SM
Oncoimmunology; 2017; 6(11):e1356148. PubMed ID: 29147608
[No Abstract] [Full Text] [Related]
17. Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma.
Ngamphaiboon N; Chureemas T; Siripoon T; Arsa L; Trachu N; Jiarpinitnun C; Pattaranutaporn P; Sirachainan E; Larbcharoensub N
Med Oncol; 2019 Jan; 36(2):21. PubMed ID: 30666437
[TBL] [Abstract][Full Text] [Related]
18. Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma.
Wei T; Leisegang M; Xia M; Kiyotani K; Li N; Zeng C; Deng C; Jiang J; Harada M; Agrawal N; Li L; Qi H; Nakamura Y; Ren L
Oncoimmunology; 2021 May; 10(1):1929726. PubMed ID: 34104546
[TBL] [Abstract][Full Text] [Related]
19. Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma.
Ida S; Takahashi H; Kawabata-Iwakawa R; Mito I; Tada H; Chikamatsu K
Oral Oncol; 2021 Nov; 122():105508. PubMed ID: 34507204
[TBL] [Abstract][Full Text] [Related]
20. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.
Wood O; Woo J; Seumois G; Savelyeva N; McCann KJ; Singh D; Jones T; Peel L; Breen MS; Ward M; Garrido Martin E; Sanchez-Elsner T; Thomas G; Vijayanand P; Woelk CH; King E; Ottensmeier C;
Oncotarget; 2016 Aug; 7(35):56781-56797. PubMed ID: 27462861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
